Larimar Therapeutics (NASDAQ:LRMR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Larimar Therapeutics (LRMR) operate in?

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Larimar Therapeutics Stock (NASDAQ: LRMR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 689.04K
Day Range	- - -
52 Wk Range	3.05 - 13.68
Market Cap	$380.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	6.54%
Days to Cover	4.22

Recent News

Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock

Oppenheimer has initiated coverage on Larimar Therapeutics, emphasizing its lead program Nomlabofusp as a transformative therapy for Friedreich's ataxia. With a price target of $26, the company plans to submit for FDA approval in late 2025, addressing a critical patient demographic.

Vandana Singh

G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 689.04K
Day Range	- - -
52 Wk Range	3.05 - 13.68
Market Cap	$380.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	6.54%
Days to Cover	4.22

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Larimar Therapeutics (LRMR) stock?

You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.

View our list of the best stock brokerages

Who are Larimar Therapeutics (LRMR) competitors?

Other companies in Larimar Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Sage Therapeutics (NASDAQ:SAGE), Sangamo Therapeutics (NASDAQ:SGMO) and Silence Therapeutics (NASDAQ:SLN).

What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?

Larimar Therapeutics has a consensus price target of $19.00.

What is the current price for Larimar Therapeutics (LRMR)?

The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $5.9561 last updated November 20, 2024 at 5:50 PM EST.

Does Larimar Therapeutics (LRMR) pay a dividend?

There are no upcoming dividends for Larimar Therapeutics.

When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?

Larimar Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Larimar Therapeutics (LRMR) going to split?

There is no upcoming split for Larimar Therapeutics.

What sector and industry does Larimar Therapeutics (LRMR) operate in?

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Larimar Therapeutics

Larimar Therapeutics (LRMR) Forecast